Author Response: Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging.

Saved in:
Bibliographic Details
Title: Author Response: Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging.
Authors: Vassilaki M; (Rochester, MN)., Pittock RR; (Chicago, IL)., Aakre JA; (Rochester, MN)., Castillo AM; (Rochester, MN)., Ramanan VK; (Rochester, MN)., Kremers WK; (Rochester, MN)., Jack CR Jr; (Rochester, MN)., Vemuri P; (Rochester, MN)., Lowe VJ; (Rochester, MN)., Knopman DS; (Rochester, MN)., Petersen RC; (Rochester, MN)., Graff-Radford J; (Rochester, MN).
Source: Neurology [Neurology] 2024 May 14; Vol. 102 (9), pp. e209377. Date of Electronic Publication: 2024 Apr 22.
Publication Type: Letter; Research Support, N.I.H., Extramural
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1526-632X (Electronic) Linking ISSN: 00283878 NLM ISO Abbreviation: Neurology Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1526-632X
DOI:10.1212/WNL.0000000000209377